161 related articles for article (PubMed ID: 34210485)
21. Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis.
Na R; Labbate C; Yu H; Shi Z; Fantus RJ; Wang CH; Andriole GL; Isaacs WB; Zheng SL; Helfand BT; Xu J
JAMA Netw Open; 2019 Dec; 2(12):e1918145. PubMed ID: 31880795
[TBL] [Abstract][Full Text] [Related]
22. Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.
Su F; Zhang W; Zhang D; Zhang Y; Pang C; Huang Y; Wang M; Cui L; He L; Zhang J; Zou L; Zhang J; Li W; Li L; Shao J; Ma J; Xiao F; Liu M
Eur Urol; 2018 Nov; 74(5):551-559. PubMed ID: 29941308
[TBL] [Abstract][Full Text] [Related]
23. The mutational landscape of prostate cancer.
Barbieri CE; Bangma CH; Bjartell A; Catto JW; Culig Z; Grönberg H; Luo J; Visakorpi T; Rubin MA
Eur Urol; 2013 Oct; 64(4):567-76. PubMed ID: 23759327
[TBL] [Abstract][Full Text] [Related]
24. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
Van Den Eeden SK; Lu R; Zhang N; Quesenberry CP; Shan J; Han JS; Tsiatis AC; Leimpeter AD; Lawrence HJ; Febbo PG; Presti JC
Eur Urol; 2018 Jan; 73(1):129-138. PubMed ID: 28988753
[TBL] [Abstract][Full Text] [Related]
25. Absence of PTEN germ-line mutations in men with a potential inherited predisposition to prostate cancer.
Cooney KA; Tsou HC; Petty EM; Miesfeldt S; Ping XL; Gruener AC; Peacocke M
Clin Cancer Res; 1999 Jun; 5(6):1387-91. PubMed ID: 10389923
[TBL] [Abstract][Full Text] [Related]
26. Recent Insights on Genetic Testing in Primary Prostate Cancer.
Kafka M; Surcel C; Heidegger I
Mol Diagn Ther; 2021 Jul; 25(4):425-438. PubMed ID: 34118026
[TBL] [Abstract][Full Text] [Related]
27. Association of E-cadherin germ-line alterations with prostate cancer.
Ikonen T; Matikainen M; Mononen N; Hyytinen ER; Helin HJ; Tommola S; Tammela TL; Pukkala E; Schleutker J; Kallioniemi OP; Koivisto PA
Clin Cancer Res; 2001 Nov; 7(11):3465-71. PubMed ID: 11705864
[TBL] [Abstract][Full Text] [Related]
28. Genetic susceptibility to prostate cancer: a review.
Verhage BA; Kiemeney LA
Fam Cancer; 2003; 2(1):57-67. PubMed ID: 14574167
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.
Chandrasekar T; Gross L; Gomella LG; Hegarty SE; Leong JY; Giri VN
Eur Urol Oncol; 2020 Jun; 3(3):291-297. PubMed ID: 31278035
[TBL] [Abstract][Full Text] [Related]
30. Hereditary Prostate Cancer: Genes Related, Target Therapy and Prevention.
Vietri MT; D'Elia G; Caliendo G; Resse M; Casamassimi A; Passariello L; Albanese L; Cioffi M; Molinari AM
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916521
[TBL] [Abstract][Full Text] [Related]
31. Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.
Setlur SR; Chen CX; Hossain RR; Ha JS; Van Doren VE; Stenzel B; Steiner E; Oldridge D; Kitabayashi N; Banerjee S; Chen JY; Schäfer G; Horninger W; Lee C; Rubin MA; Klocker H; Demichelis F
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):229-39. PubMed ID: 20056642
[TBL] [Abstract][Full Text] [Related]
32. An Interleukin-6 Single Nucleotide Polymorphism and Susceptibility to Prostate Adenocarcinoma and Bone Metastasis in an Iranian Population.
Dargahi Abbasabad G; Banan Khojasteh SM; Eskandari Naji H; Zamani MR; Hajipour H; Serati-Nouri H
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1717-1720. PubMed ID: 29938471
[TBL] [Abstract][Full Text] [Related]
33. Basic Science and Molecular Genetics of Prostate Cancer Aggressiveness.
Schiewer MJ; Knudsen KE
Urol Clin North Am; 2021 Aug; 48(3):339-347. PubMed ID: 34210489
[TBL] [Abstract][Full Text] [Related]
34. Screening for familial and hereditary prostate cancer.
Lynch HT; Kosoko-Lasaki O; Leslie SW; Rendell M; Shaw T; Snyder C; D'Amico AV; Buxbaum S; Isaacs WB; Loeb S; Moul JW; Powell I
Int J Cancer; 2016 Jun; 138(11):2579-91. PubMed ID: 26638190
[TBL] [Abstract][Full Text] [Related]
35. Genetic Testing Guidelines and Education of Health Care Providers Involved in Prostate Cancer Care.
Mark JR; McDougall C; Giri VN
Urol Clin North Am; 2021 Aug; 48(3):311-322. PubMed ID: 34210487
[TBL] [Abstract][Full Text] [Related]
36. Metastatic Prostate Cancer: Effects of Genetic Testing on Care.
Connors LM
Clin J Oncol Nurs; 2019 Feb; 23(1):32-35. PubMed ID: 30681994
[TBL] [Abstract][Full Text] [Related]
37. Genetic testing for the clinician in prostate cancer.
López-Campos F; Linares-Espinós E; Maldonado Pijoan X; Sancho Pardo G; Morgan TM; Martínez-Ballesteros C; Martínez-Salamanca J; Couñago F
Expert Rev Mol Diagn; 2020 Sep; 20(9):933-946. PubMed ID: 32885704
[TBL] [Abstract][Full Text] [Related]
38. CYP17 gene polymorphism and prostate cancer susceptibility in a Tunisian population.
Souiden Y; Mahdouani M; Chaieb K; Elkamel R; Mahdouani K
Cancer Epidemiol; 2011 Oct; 35(5):480-4. PubMed ID: 21193363
[TBL] [Abstract][Full Text] [Related]
39. A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.
Nordström T; Aly M; Eklund M; Egevad L; Grönberg H
Eur Urol; 2014 Jun; 65(6):1184-90. PubMed ID: 23891454
[TBL] [Abstract][Full Text] [Related]
40. Inherited risk assessment of prostate cancer: it takes three to do it right.
Xu J; Labbate CV; Isaacs WB; Helfand BT
Prostate Cancer Prostatic Dis; 2020 Mar; 23(1):59-61. PubMed ID: 31417171
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
